Awareness of preventive medication among women at high risk for breast cancer and their willingness to consider transdermal or oral tamoxifen: a focus group study

BACKGROUND: Despite demonstrated efficacy, acceptance of selective estrogen receptor modulators (SERMs), such as tamoxifen, for breast cancer risk reduction remains low. Delivering SERMs via local transdermal therapy (LTT) could significantly reduce systemic effects and therefore may increase accept...

Descripción completa

Detalles Bibliográficos
Autores principales: Karavites, Lindsey C., Allu, Subhashini, Khan, Seema A., Kaiser, Karen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4640234/
https://www.ncbi.nlm.nih.gov/pubmed/26552376
http://dx.doi.org/10.1186/s12885-015-1893-6

Ejemplares similares

Ejemplares similares